title: Type II Na+-Pi cotransporters in osteoblast mineral formation: regulation by inorganic phosphate.
abstract: During calcification of bone, large amounts of phosphate (P(i)) must be transported from the circulation to the osteoid. Likely candidates for osteoblast P(i) transport are the type II sodium-phosphate cotransporters NaPi-IIa and NaPi-IIb that facilitate transcellular P(i) flux in kidney and intestine, respectively. We have therefore determined the 'cotransporters' expression in osteoblast-like cells. We have also studied the 'cotransporters' regulation by P(i) and during mineralization in vitro. Phosphate uptake and cotransporter protein expression was investigated at early, late and mineralizing culture stages of mouse (MC3T3-E1) and rat (UMR-106) osteoblast-like cells. Both NaPi-IIa and NaPi-IIb were expressed by both osteoblast-like cell lines. NaPi-IIa was upregulated in both cell lines one week after confluency. After 7 days in 3mM P(i) NaPi-IIa was strongly upregulated in both cell lines. NaPi-IIb expression was unaffected by both culture stage and P(i) supplementation. The expression of both cotransporters was unaffected by P(i) deprivation. In vitro mineralization at 1.5mM P(i) was preceded by a three-fold increase in osteoblast sodium-dependent P(i) uptake and a corresponding upregulation of both NaPi-IIa and NaPi-IIb. Their expression thus seem regulated by phosphate in a manner consistent with their playing a role in transcellular P(i) flux during mineralization.
authors.affiliation: Institute for Physiology and Center for Integrative Human Physiology, University of Zürich, Switzerland. patrik@physiol.unizh.ch
authors.forename: Patrik
authors.initials: P
authors.lastname: Lundquist
authors.forename: Heini
authors.initials: H
authors.lastname: Murer
authors.forename: Jürg
authors.initials: J
authors.lastname: Biber
mesh_terms: D000818:Animals; D002113:Calcification, Physiologic / Q000187:drug effects*; D002460:Cell Line; D005786:Gene Expression Regulation; D051379:Mice; D010006:Osteoblasts / Q000187:drug effects* / Q000378:metabolism; D010710:Phosphates / Q000493:pharmacokinetics / Q000494:pharmacology*; D016226:Phosphorus, Dietary / Q000494:pharmacology; D051381:Rats; D050611:Sodium-Phosphate Cotransporter Proteins, Type III; D050613:Sodium-Phosphate Cotransporter Proteins, Type IIa / Q000378:metabolism*; D050614:Sodium-Phosphate Cotransporter Proteins, Type IIb / Q000378:metabolism*
chemical_list: D010710:Phosphates; D016226:Phosphorus, Dietary; D050611:Sodium-Phosphate Cotransporter Proteins, Type III; D050613:Sodium-Phosphate Cotransporter Proteins, Type IIa; D050614:Sodium-Phosphate Cotransporter Proteins, Type IIb